Literature DB >> 24810391

Dose-related association between urinary cotinine-verified smoking status and dyslipidemia among Korean men: the 2008-2010 Korea National Health and Nutrition Examination Survey.

Ga Eun Nam1, Do Hoon Kim, Yong Gyu Park, Kyungdo Han, Youn Seon Choi, Seon Mee Kim, Byung Joon Ko, Yang Hyun Kim, Kyung Shik Lee, Sung Joon Baek.   

Abstract

This cross-sectionally designed study was based on data collected during the 2008-2010 Korea National Health and Nutrition Examination Survey. A total 3231 South Korean men aged more than 19 years were included. Urinary cotinine concentrations were measured. Smoking status was defined using questionnaire responses and urinary cotinine concentrations. Hierarchical multivariate logistic regression analyses were used to assess the association of urinary cotinine concentrations with the prevalence of dyslipidemia and various parameters of dyslipidemia. There is a significant dose-related association between smoking as assessed by urinary cotinine concentration and dyslipidemia and various parameters of dyslipidemia among South Korean men.

Entities:  

Keywords:  dyslipidemia; smoking; urinary cotinine

Mesh:

Substances:

Year:  2014        PMID: 24810391     DOI: 10.3109/10826084.2014.912227

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  2 in total

1.  Dose-Dependent Toxic Effect of Cotinine-Verified Tobacco Smoking on Systemic Inflammation in Apparently Healthy Men and Women: A Nationwide Population-Based Study.

Authors:  Won-Jun Choi; Ji-Won Lee; A Ra Cho; Yong-Jae Lee
Journal:  Int J Environ Res Public Health       Date:  2019-02-11       Impact factor: 3.390

2.  Association between cotinine-verified smoking status and moderately increased albuminuria in the middle-aged and older population in Korea: A nationwide population-based study.

Authors:  Yeonjoo Choi; Joo-Hyun Park; Do-Hoon Kim; Hyun Jin Kim; Euijung Suh; Ki-Hoon Kim; Jae Joon Ahn; Gyu-Na Lee; Jin-Hyung Jung; Kyungdo Han; You-Na Shin
Journal:  PLoS One       Date:  2021-02-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.